Addex Therapeutics Ltd Price & Performance (ADXN)
Stock Performance
ADXN:NASDAQ
$7.60USD0.78% · $0.06
After Hours
+8.98% · $0.68
- $7.88
- $7.95
- $7.54
- $6.23M
- -0.4
- 3.84K
- $27.90
- $6.67
Open
High
Low
Market Cap
P/E Ratio
Volume
Year High
Year Low
What's Happening
Peers
Income Statement
Revenue
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
Revenue | CHF 2.8M | CHF 3.6M | CHF 2.9M | CHF 1.4M | CHF 1.6M |
Cost of Revenue | CHF 230K | CHF 10M | CHF 13M | CHF 15M | CHF 6.9M |
Gross Profit | CHF 2.5M | -CHF 6.8M | -CHF 9.9M | -CHF 13M | -CHF 5.3M |
Gross Profit % | 92% | -187% | -340% | -928% | -330% |
R&D Expenses | CHF 12M | CHF 10M | CHF 13M | CHF 15M | CHF 2.7M |
Cash Flow
Net Income
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
Net Income | -CHF 15M | -CHF 13M | -CHF 15M | -CHF 21M | -CHF 11M |
Dep. & Amort. | CHF 334K | CHF 379K | CHF 348K | CHF 323K | CHF 306K |
Def. Tax | CHF 97K | -CHF 28K | -CHF 151K | CHF 0 | CHF 0 |
Stock Comp. | CHF 1.7M | CHF 1.2M | CHF 1.2M | CHF 3.7M | CHF 1.8M |
Chg. in WC | CHF 2.7M | -CHF 1.8M | -CHF 762K | CHF 158K | CHF 214K |
Balance Sheet
Cash
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
Cash | CHF 32M | CHF 19M | CHF 20M | CHF 7M | CHF 3.9M |
ST Investments | CHF 14K | CHF 65K | CHF 17K | CHF 3.2K | CHF 848 |
Cash & ST Inv. | CHF 32M | CHF 19M | CHF 21M | CHF 7M | CHF 3.9M |
Receivables | CHF 118K | CHF 68K | CHF 324K | CHF 598K | CHF 151K |
Inventory | -CHF 14K | CHF 163K | CHF 1 | -CHF 872M | CHF 0 |
Related
Financial information provided by Financial Modeling Prep. Options data provided by Unusual Whales. Live transcripts provided by Quartr. All data is provided for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. · See all tickers.